Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues
Genome Medicine
In Press
Using genomics in medicine
Franca Sozzani has inspired a scientific fund – And now a website
Vogue |
December 2020
Press
“Last year Sozzani’s son, the photographer and filmmaker Francesco Carrozzini, established the Franca Sozzani Fund for Preventive Genomics at Harvard University’s Brigham and Women’s Hospital with artist and investor D.A. Wallach and Genomes2People director Dr. Robert C. Green. Today marks the launch of thefrancafund.org. Its purpose is straightforward: to explain the fund’s mission, provide resources … Continued
The future of genomics in Ireland – focus on genomics for health
HRB Open Research
December 2020
Race, ancestry, and representation: The role of genetic medicine
Medium |
September 2020
G2P Blog
Race is a social construct, but representation matters in genetic studies — and on that front, we have a long way to go. By Tala Berro, MS, CGC
Long-awaited progress in addressing genetic discrimination in the US
Genetics in Medicine
October 2020
Genomic sequencing to screen newborns raises more false alarms than routine blood tests
STAT |
August 2020
Press
In this study led by UCSF researchers, exome sequencing was found to produce more false positives and false negatives for inherited metabolic disorders than the standard blood testing conducted in newborns. G2P’s Dr. Robert Green, co-leader of the BabySeq Project, speaks to the possibility “that the most comprehensive screening for newborns will be some combination … Continued
FDA oversight of NSIGHT genomic research: the need for an integrated systems approach to regulation
npj Genomic Medicine
December 2019
Biobanks could identify medically actionable findings relevant for COVID-19 clinical care
Nature Medicine
June 2020
Educating military primary health-care providers in genomic medicine: lessons learned from the MilSeq Project
Genetics in Medicine
July 2020
Genetic counseling following direct-to-consumer genetic testing: Consumer perspectives
Journal of Genetic Counseling
July 2020
The Project Baseline Health Study: A step towards a broader mission to map human health
npj Digital Medicine
June 2020
The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic
European Journal of Human Genetics
May 2020
Understanding the return of genomic sequencing results process: Content review of participant summary letters in the eMERGE research network
Journal of Personalized Medicine
May 2020
Geneticist says DNA testing should be part of everyday healthcare
CNBC |
May 2020
Press, Video
Dr. Robert Green is the director of the Preventive Genomics Clinic at Brigham and Women’s Hospital in Boston. He believes that DNA testing combined with proper counseling and medical follow-up would be a critical element of a healthcare system that can prevent illness.
Coronavirus, the answer may be in your genes
Fox News |
May 2020
Press, Video
What do your genetics have to do with your chances of dying from Coronavirus?
Vanity Fair |
April 2020
Press
Our genes might make some of us more susceptible to COVID-19—but which genes? Geneticists are sharing their vast DNA databases to find out.
Heroes on the front line: Dr. Robert Green
Blue Cross Blue Shield Massachusetts |
April 2020
Press
“..There are researchers – every single scientist is thinking ‘how can I contribute?’”
Returning results in the genomic era: Initial experiences of the eMERGE network
Journal of Personalized Medicine
April 2020
Clinical utility of genomic sequencing: a measurement toolkit
npj Genomic Medicine
December 2020
Coronavirus: Genes may explain why some face greater danger than others
Fox News |
April 2020
Press
“While healthy young people as a group are less likely to have severe symptoms with COVID, they have to understand that some of them will become very ill and will even die from this infection,” Dr. Robert Green said. “No one should assume youth makes them invulnerable.”
Genome-wide association study of rate of cognitive decline in Alzheimer’s patients identifies novel genes and pathways
Alzheimer's & Dementia
June 2020
Of Known Significance
Clinical Omics |
March 2020
Press
An exclusive Clinical OMICs conversation with the director of Genomes2People, Robert Green, M.D., MPH
Should everyone have their full genome sequenced? A Conversation with Robert Green, MD, head of Genomes2People at Brigham and Women’s and Founder of Genome Medical
Touch Point Media |
March 2020
Podcast
Greg and Robert explode some of the persistent myths around genetic testing and dive in to the future of genetic testing amongst healthy populations
Quantifying downstream health care utilization in studies of genomic testing
Value in Health
March 2020
All in for All of Us
Brigham Clinical and Research News |
March 2020
Press
Through national research efforts like the All of Us Research Program, Brigham investigators and their collaborators are making genomic research more meaningful, equitable and impactful for all patients at the Brigham and around the world.
Ultra-fast genome sequencing could save the lives of newborns
Wired |
March 2020
Press
Whole genome tests can help identify the cause of a baby’s mysterious illness. But ethicists say it’s still too soon to use them for all infants.
Creation and utility of “Boston Minority Genetic Counselors’
Journal of Genetic Counseling
February 2020
Consumer DNA testing is a bust: Here’s how companies like Ancestry and 23andMe can survive
CNBC |
February 2020
Press
“Our research is finding that genetics is about to take its rightful place in medical care for the world.” said Dr. Robert Green, a professor of genetics at Harvard Medical School.
Econogenomics: The economics of genomic testing for health
Medium |
January 2020
G2P Blog
“The cost of sequencing itself is already comparable to a lot of other diagnostic tests regularly used in medicine,” Kurt Christensen, PhD said. Besides: “What really moves the needle on cost effectiveness isn’t the costs — it’s the benefits.”
New tests use epigenetics to guess how fast you’re aging
Wired |
December 2019
Press
Companies claim they can now easily calculate your biological age. Should you take them up on it?
Pragmatic trials in genomic medicine: The Integrating Pharmacogenetics in Clinical Care (I-PICC) study
Clinical and Translational Science
December 2019
Reset your DNA to slow the clock
Neo Life |
December 2019
Press
A new epigenetic test that tracks molecular aging claims to show you how to stay biologically young. However, Robert Green says “epigenetic marks in apparently healthy people can tell them meaningful things about their health status is an overreach.”
Apple is offering free genetic tests to all its Silicon Valley employees
CNBC |
December 2019
Press
“It’s really exciting that to see companies move to preserve health, rather than just treating patients when they’re ill,” said Dr. Robert Green, a medical geneticist at Harvard Medical School and a co-founder of a genetics company called Genome Medical.
The case for implementing sustainable routine, population-level genomic reanalysis
Genetics in Medicine
December 2019
Addressing barriers to expanding genetic counseling
Modern Health Care |
November 2019
Press
Genetic counselors are becoming a bigger part of the healthcare continuum as population health management seeks to more quickly screen for, assess and prevent illness. Read on as genetic counselors in the field, including our own, Carrie Blout, address some of the barriers in genetic counseling.
China’s genetics giant wants to tailor medicine to your DNA
Bloomberg |
November 2019
Press
BGI is racing toward a world where your DNA informs your medical decisions—and maybe some of your personal ones. Bloomberg asks Dr. Robert Green on his thoughts regarding the medical advances in genomics in China and how they compare to those in the US.
Predictive and precision medicine with genomic data
Clinical Chemistry
January 2020
